Aggressive care at the end of life: A study of practice based factors in patients with stage IV cancer.

Authors

null

Mohammad Omar Atiq

University of Arkansas for Medical Sciences, Little Rock, AR

Mohammad Omar Atiq, Rahul Ravilla, Ajay Kumar, Sajjad Haider, Ji-Ling Tang, Konstantinos Arnaoutakis, Pooja Motwani, Eric R Siegel, Appalanaidu Sasapu, Fade A. Mahmoud, Sarah Elizabeth Harrington

Organizations

University of Arkansas for Medical Sciences, Little Rock, AR, UAMS, Little Rock, AR, University of Arkansas for Medical Science, Little Rock, AR, University of Arkansas For Medical Science, Little Rock, AR, University of Arkansas for Medical Sciences Hematology/Oncology Department, Little Rock, AR

Research Funding

Other

Background: Numerous studies established that early utilization of palliative care-hospice services are beneficial to cancer patients. To reduce the incidence of aggressive care in terminal cancer patients, we conducted a quality improvement study to identify pertinent risk factors and develop interventions. Methods: Through chart review, we retrospectively identified patients with stage IV cancer that were followed by oncology clinic and were admitted to the University Hospital between 8/1/2015-10/31/15. For those patients who died during the last hospitalization or were discharged to hospice care, we obtained demographic, cancer related and practice related variables listed in Table. We used Mann Whitney U test and multivariable regression to find effects of factors related to length of stay (LOS) and cost of stay (COS). Results: Length of stay was significantly prolonged in those receiving chemotherapy within the past month (6 vs 3 p=0.035). Multivariate analyses found that patients with goals of care documented in the clinic had lower COS by 36.7% and LOS by 46.7%. On average, an ICU stay resulted in COS 2.2 times higher. No significant difference was seen in LOS based on a documented palliative care clinic visit or presence of an advanced directive. Conclusions: We identified practice based factors that need improvement including earlier goals of care conversations and less chemotherapy at the end of life. Identifying end stage patients in earlier admissions, collaborating with palliative care, and adding goals of care documentation to clinic note templates, are all interventions we are studying to improve care for end stage cancer patients.

Patient characteristics (N=46).

Race, N (%)
    White34 (74)
    Black12 (26)
Gender
    Male24 (52)
    Female22 (48)
Cancer
    Lung17 (37)
    Breast5 (11)
    Other24 (52)
Chemotherapy within one month
    Yes27 (59)
    No19 (41)
Goals of care documented in Clinic
    Yes16 (35)
    No30 (65)
Stayed in ICU
    Yes16 (35)
    No30 (65)
Followed in Palliative Care Clinic
    Yes14 (30)
    No32 (70)
ECOG Status Documented
    Yes23 (50)
    No23 (50)
Advanced Directive
    Yes11 (24)
    No35 (76)
Died in hospital
    Yes11 (24)
    No35 (76)
Admissions in past 3 months, Median2
COS in $, Median (Q1, Q3)17254 (12199, 45443)
LOS in Days, Median (Q1, Q3)4 (2, 9)

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2017 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cost, Value, and Policy in Quality; Practice of Quality

Track

Cost, Value, and Policy in Quality,Practice of Quality

Sub Track

Learning from Projects Done in a Practice

Citation

J Clin Oncol 35, 2017 (suppl 8S; abstract 80)

DOI

10.1200/JCO.2017.35.8_suppl.80

Abstract #

80

Poster Bd #

C21

Abstract Disclosures